Literature DB >> 4042977

Skin is an active site for the inner ring monodeiodination of thyroxine to 3,3',5'-triiodothyronine.

T S Huang, I J Chopra, A Beredo, D H Solomon.   

Abstract

T4 (0.26 microM) was incubated in 0.1 M phosphate buffer (pH 7.4) containing 10 mM EDTA with homogenates (3-5 mg protein) of various rat tissues and up to 400 mM dithiothreitol (DTT) for 1 h at 37 C; the rT3 generated was measured by RIA of ethanol extracts of the incubation mixture. Among the various tissues of the male rat, homogenates of skin and cerebral cortex were very active in the conversion of T4 to rT3; other tissues demonstrated little or no T4 5-monodeiodinating activity (MA). The tissue content of rT3 was also greatest in these two tissues. The MA in skin increased linearly with incubation period (up to 4 h) and with increasing concentration of protein (up to 5 mg), substrate (up to 10 microM) and DTT (up to 400 mM); its optimal pH was 7.4, and optimal temperature was 37 C. Its Km and maximum velocity approximated 0.29 microM and 9.6 pmol/h X mg protein, respectively, in the presence of 400 mM DTT. There was no appreciable difference in T4 to rT3 MA of skin from different parts of the body. The MA was most abundant in microsomes and least in cytosol. The MA was unaffected by propylthiouracil (up to 25 microM), methimazole (up to 100 microM), sodium salicylate (up to 80 microM), or 8-anilino-1-naphthalene sulfonic acid (up to 75 microM). Ipodate (up to 80 microM) weakly inhibited the MA. T3 and 3,5-diiodothyronine inhibited dermal T4 to rT3 MA in a dose-dependent manner; T3 was 3-12 times more potent than 3,5-diiodothyronine on a molar basis in different experiments. Treatment of euthyroid rats with 3,5-dimethyl-3'isopropylthyronine (45 micrograms/day, ip) for 3 or 5 days significantly increased dermal T4 to rT3 MA. Similar treatment of rats with T4 (100 micrograms/day, ip) or T3 (20 or 80 micrograms/day, ip) did not change with MA appreciably. Hypothyroidism markedly inhibited the MA, and fasting inhibited it modestly. Pregnancy was associated with marked reduction in the MA of skin in the mother [0.30 +/- 0.11 (+/- SE) vs. 7.2 +/- 2.2 ng/h X mg protein; P less than 0.02] and fetus (0.67 +/- 0.075; P less than 0.025).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4042977     DOI: 10.1210/endo-117-5-2106

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

1.  Type 3 deiodinase is critical for the maturation and function of the thyroid axis.

Authors:  Arturo Hernandez; M Elena Martinez; Steven Fiering; Valerie Anne Galton; Donald St Germain
Journal:  J Clin Invest       Date:  2006-01-12       Impact factor: 14.808

Review 2.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

Review 3.  Thyroid diseases and skin autoimmunity.

Authors:  Enke Baldini; Teresa Odorisio; Chiara Tuccilli; Severino Persechino; Salvatore Sorrenti; Antonio Catania; Daniele Pironi; Giovanni Carbotta; Laura Giacomelli; Stefano Arcieri; Massimo Vergine; Massimo Monti; Salvatore Ulisse
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

4.  Impaired local deiodination of thyroxine to triiodothyronine in dogs with symmetrical truncal alopecia.

Authors:  P Rudas; T Bartha; J Toth; V L Frenyo
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

5.  Alterations in 3,3'5'-triiodothyronine metabolism in response to propylthiouracil, dexamethasone, and thyroxine administration in man.

Authors:  J S LoPresti; A Eigen; E Kaptein; K P Anderson; C A Spencer; J T Nicoloff
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

Review 6.  Genomic imprinting of the type 3 thyroid hormone deiodinase gene: regulation and developmental implications.

Authors:  Marika Charalambous; Arturo Hernandez
Journal:  Biochim Biophys Acta       Date:  2012-04-04

7.  Metabolism of reverse triiodothyronine by isolated rat hepatocytes.

Authors:  S J Rooda; M A van Loon; T J Visser
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

8.  Evidence against benefit from replacement doses of thyroid hormones in nonthyroidal illness (NTI): studies using turpentine oil-injected rat.

Authors:  I J Chopra; T S Huang; R Boado; D H Solomon; G N Chua Teco
Journal:  J Endocrinol Invest       Date:  1987-12       Impact factor: 4.256

Review 9.  Thyroid hormone action in epidermal development and homeostasis and its implications in the pathophysiology of the skin.

Authors:  G Mancino; C Miro; E Di Cicco; M Dentice
Journal:  J Endocrinol Invest       Date:  2021-03-08       Impact factor: 4.256

10.  Thyroid hormone and wound healing.

Authors:  Joshua D Safer
Journal:  J Thyroid Res       Date:  2013-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.